- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted therapies for thyroid tumors
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 24, Issue S2, Pages S44-S52
Publisher
Springer Nature
Online
2011-04-01
DOI
10.1038/modpathol.2010.165
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Response to Sunitinib in Medullary Thyroid Cancer
- (2013) Fergal C. Kelleher et al. ANNALS OF INTERNAL MEDICINE
- Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma
- (2010) Sarah-Jane Dawson et al. ANTI-CANCER DRUGS
- Cytotoxic Chemotherapy for Differentiated Thyroid Carcinoma
- (2010) S.I. Sherman CLINICAL ONCOLOGY
- Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Bruce G. Robinson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment with Tyrosine Kinase Inhibitors for Patients with Differentiated Thyroid Cancer: the M. D. Anderson Experience
- (2010) Maria E. Cabanillas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
- (2010) Elaine T. Lam et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited
- (2009) Sonja Loges et al. CANCER CELL
- Cutaneous Squamous Cell Carcinoma and Inflammation of Actinic Keratoses Associated with Sorafenib
- (2009) Zita Dubauskas et al. Clinical Genitourinary Cancer
- Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets
- (2009) Jeffrey A Knauf et al. CURRENT OPINION IN CELL BIOLOGY
- Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
- (2009) Hendrieke Hoftijzer et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors inBRAFMutant Thyroid Carcinoma Cells
- (2009) Paolo Salerno et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- BRAF Mutation Testing of Thyroid Fine-Needle Aspiration Biopsy Specimens for Preoperative Risk Stratification in Papillary Thyroid Cancer
- (2009) Mingzhao Xing et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
- (2009) Martin J. Schlumberger et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
- (2009) Richard T. Kloos et al. JOURNAL OF CLINICAL ONCOLOGY
- Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
- (2009) Benjamin D. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma
- (2009) L. Santarpia et al. JOURNAL OF INTERNAL MEDICINE
- The Successful Use of Sorafenib to Treat Pediatric Papillary Thyroid Carcinoma
- (2009) Steven G. Waguespack et al. THYROID
- International patterns and trends in thyroid cancer incidence, 1973–2002
- (2008) Briseis A. Kilfoy et al. CANCER CAUSES & CONTROL
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- BRAFV600EMutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
- (2008) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study
- (2008) Ezra E.W. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Refractory Thyroid Cancer: A Paradigm Shift in Treatment Is Not Far Off
- (2008) David G. Pfister et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAF Silencing by Short Hairpin RNA or Chemical Blockade by PLX4032 Leads to Different Responses in Melanoma and Thyroid Carcinoma Cells
- (2008) E. Sala et al. MOLECULAR CANCER RESEARCH
- Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer
- (2008) Steven I. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug Insight: gastrointestinal stromal tumors (GIST)—the solid tumor model for cancer-specific treatment
- (2008) Stefan Sleijfer et al. Nature clinical practice. Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started